| scholarly article | Q13442814 |
| P2093 | author name string | Gil Mor | |
| Ayesha B Alvero | |||
| Michele K Montagna | |||
| Vinicius Craveiro | |||
| Lanzhen Liu | |||
| P2860 | cites work | Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells | Q24618984 |
| M-1/M-2 macrophages and the Th1/Th2 paradigm | Q28145893 | ||
| Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance | Q28307294 | ||
| Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes | Q29547633 | ||
| Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival | Q29547865 | ||
| Tumour-educated macrophages promote tumour progression and metastasis | Q29614307 | ||
| The many faces of macrophage activation | Q29617449 | ||
| Stem-like ovarian cancer cells can serve as tumor vascular progenitors | Q30491933 | ||
| Resistance of ovarian carcinoma cells to docetaxel is XIAP dependent and reversible by phenoxodiol. | Q33211124 | ||
| Blocking TLR2 activity attenuates pulmonary metastases of tumor | Q33490618 | ||
| Alternative versus classical activation of macrophages. | Q33868142 | ||
| Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer | Q34210036 | ||
| Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer | Q34843832 | ||
| Enhanced stimulation of anti-ovarian cancer CD8(+) T cells by dendritic cells loaded with nanoparticle encapsulated tumor antigen | Q34860928 | ||
| Ovarian cancer stem cells and inflammation | Q35001138 | ||
| Macrophages and apoptotic cell clearance during pregnancy | Q35814538 | ||
| Macrophage polarization comes of age. | Q36287066 | ||
| Dendritic cells are specialized accessory cells along with TGF- for the differentiation of Foxp3+ CD4+ regulatory T cells from peripheral Foxp3 precursors | Q36447894 | ||
| Inflammation, cancer and chemoresistance: taking advantage of the toll-like receptor signaling pathway | Q36705250 | ||
| Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study | Q36912591 | ||
| Two unique human decidual macrophage populations. | Q37015896 | ||
| Depletion of dendritic cells delays ovarian cancer progression by boosting antitumor immunity. | Q37342848 | ||
| Intraepithelial T cells and tumor proliferation: impact on the benefit from surgical cytoreduction in advanced serous ovarian cancer | Q37369523 | ||
| Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis | Q40109430 | ||
| TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer | Q40296306 | ||
| Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. | Q40400391 | ||
| Cytokines and macrophages | Q40594324 | ||
| Phenoxodiol – an isoflavone analog – induces apoptosis in chemoresistant ovarian cancer cells | Q40650033 | ||
| Macrophages, estrogen and the microenvironment of breast cancer | Q40971265 | ||
| Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors. | Q47829471 | ||
| Epithelial ovarian cancer cells secrete functional Fas ligand | Q52552098 | ||
| The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. | Q53646174 | ||
| Transforming growth factor beta 1 plays an important role in inducing CD4(+)CD25(+)forhead box P3(+) regulatory T cells by mast cells. | Q54424235 | ||
| Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type and BRCA1 loss | Q61626110 | ||
| Ovarian cancer. Clinical practice guidelines in oncology | Q79620959 | ||
| Macrophage migration inhibitory factor expression in ovarian cancer | Q80086308 | ||
| Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer | Q80458732 | ||
| Diagnostic markers for early detection of ovarian cancer | Q80656320 | ||
| P433 | issue | 3 | |
| P921 | main subject | ovarian cancer | Q172341 |
| P304 | page(s) | 256-265 | |
| P577 | publication date | 2011-09-14 | |
| P1433 | published in | American Journal of Reproductive Immunology | Q15761228 |
| P1476 | title | Distinct subpopulations of epithelial ovarian cancer cells can differentially induce macrophages and T regulatory cells toward a pro-tumor phenotype | |
| P478 | volume | 67 |
| Q51238643 | Adipocyte microenvironment promotes Bclxl expression and confers chemoresistance in ovarian cancer cells. |
| Q48225463 | Deoxyschizandrin, Isolated from Schisandra Berries, Induces Cell Cycle Arrest in Ovarian Cancer Cells and Inhibits the Protumoural Activation of Tumour-Associated Macrophages |
| Q36989613 | Effect of culture conditions on the phenotype of THP-1 monocyte cell line |
| Q47151222 | Influence of ovarian cancer type I and type II microenvironment on the phenotype and function of monocyte-derived dendritic cells. |
| Q39205417 | Interaction of monocytes/macrophages with ovarian cancer cells promotes angiogenesis in vitro |
| Q42290425 | Interleukin 21 inhibits cancer-mediated FOXP3 induction in naïve human CD4 T cells |
| Q21198790 | Involvement of autophagy in ovarian cancer: a working hypothesis |
| Q36267621 | Microenvironmental effects limit efficacy of thymoquinone treatment in a mouse model of ovarian cancer |
| Q30244214 | Minireview: Regulatory T Cells and Ovarian Cancer. |
| Q34483738 | Multiple blocks in the engagement of oxidative phosphorylation in putative ovarian cancer stem cells: implication for maintenance therapy with glycolysis inhibitors |
| Q34063581 | Ovulation and extra-ovarian origin of ovarian cancer |
| Q28387330 | Peripheral blood immune cell methylation profiles are associated with nonhematopoietic cancers |
| Q37442989 | Preoperative Monocyte-to-Lymphocyte Ratio in Peripheral Blood Predicts Stages, Metastasis, and Histological Grades in Patients with Ovarian Cancer |
| Q48200688 | Pro-inflammatory M1 macrophage enhances metastatic potential of ovarian cancer cells through NF-κB activation |
| Q47773956 | Revisiting ovarian cancer microenvironment: a friend or a foe? |
| Q36654413 | TLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrence |
| Q34365639 | TWIST and ovarian cancer stem cells: implications for chemoresistance and metastasis |
| Q51065824 | The analysis of metallothionein immunoreactivity in stromal fibroblasts and macrophages in cases of uterine cervical carcinoma with respect to both the local and distant spread of the disease. |
| Q36919484 | The duplicitous origin of ovarian cancer |
| Q33659166 | The therapeutic potential of class I selective histone deacetylase inhibitors in ovarian cancer |
| Q37355822 | Tracking NF-κB activity in tumor cells during ovarian cancer progression in a syngeneic mouse model |
| Q34503570 | Trophoblast induces monocyte differentiation into CD14+/CD16+ macrophages |
| Q33718878 | Tumor-associated macrophages contribute to tumor progression in ovarian cancer. |
Search more.